Early research (Phase 1)Study completedNCT00049296What this trial is testingThalidomide and Docetaxel in Treating Patients With Advanced CancerWho this might be right forCancer Case Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)Ended earlyNCT01418742What this trial is testingSKIP - A Double-blind Placebo-controlled Randomized Multicenter Trial of Skin Toxicity TreatmentWho this might be right forColorectal Carcinoma Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH 11
Testing effectiveness (Phase 2)Study completedNCT00775073What this trial is testingAntiangiogenic Treatment of Hepatocellular Cancer With Bevacizumab and RAD001Who this might be right forHepatocellular Carcinoma Gerhard Treiber 33
Early research (Phase 1)Ended earlyNCT05904496What this trial is testingBGB-30813 Alone or in Combination With Tislelizumab in Participants With Advanced or Metastatic Solid TumorsWho this might be right forAdvanced Solid Tumors BeiGene 44
Large-scale testing (Phase 3)Study completedNCT03191786What this trial is testingAtezolizumab Compared With a Single-Agent Chemotherapy in Treatment Naïve Participants With Locally Advanced or Recurrent or Metastatic Non-Small Cell Lung Cancer Who Are Deemed Unsuitable For Platinum-Doublet ChemotherapyWho this might be right forNon-Small Cell Lung Cancer Hoffmann-La Roche 453
Testing effectiveness (Phase 2)UnknownNCT05189483What this trial is testingAlbumin-bound Paclitaxel Plus Camrelizumab for Advanced Soft Tissue Sarcoma.Who this might be right forSoft Tissue Sarcoma Henan Cancer Hospital 40
Large-scale testing (Phase 3)Study completedNCT00290966What this trial is testingRandomized Multicenter Study Comparing Docetaxel Plus Cisplatin and 5-FU to Cisplatin Plus 5-FU in Advanced Gastric CancerWho this might be right forStomach Neoplasm Sanofi 610
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07630103What this trial is testingEfficacy and Safety of Trastuzumab Rezetecan or Trastuzumab Deruxtecan in Advanced Breast CancerWho this might be right forAdvanced Breast Cancer Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 100
Testing effectiveness (Phase 2)Study completedNCT02358161What this trial is testingPhase I/II Study of LDE225 With Gemcitabine and Nab-paclitaxel in Patients With Pancreatic CancerWho this might be right forPancreatic Cancer Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 78
Early research (Phase 1)Looking for participantsNCT06374173What this trial is testingEvaluate TGI-6 in Subjects With Locally Advanced/Metastatic Solid TumorsWho this might be right forAdvanced or Metastatic Solid Tumors Hefei TG ImmunoPharma Co., Ltd. 123
Not applicableStudy completedNCT05314179What this trial is testingUbuntu - I Am Because We AreWho this might be right forMetastatic Cancer University of Pittsburgh 15
Early research (Phase 1)Looking for participantsNCT07504523What this trial is testingPersonalized T-Cell Therapy iNeo-Vac-T01 in Advanced Colorectal CancerWho this might be right forMetastatic Colorectal Cancer (CRC) Ying Yuan, MD 20
Testing effectiveness (Phase 2)Study completedNCT01216696What this trial is testingIpilimumab in Patients With Advanced Melanoma and Spontaneous Preexisting Immune Response to NY-ESO-1Who this might be right forMetastatic Melanoma National Center for Tumor Diseases, Heidelberg 25
Testing effectiveness (Phase 2)Ended earlyNCT00817362What this trial is testingEfficacy and Safety of IPI-504 With Trastuzumab Pretreated, Locally Advanced or Metastatic HER2 Positive Breast CancerWho this might be right forBreast CancerHER2 Positive Breast CancerMetastatic Breast Cancer+1 more Infinity Pharmaceuticals, Inc. 29
Large-scale testing (Phase 3)UnknownNCT00532727What this trial is testingTriple Negative Breast Cancer TrialWho this might be right forBreast Cancer Institute of Cancer Research, United Kingdom 400
Large-scale testing (Phase 3)Active Not RecruitingNCT05382286What this trial is testingStudy of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast CancerWho this might be right forTriple Negative Breast CancerPD-L1 Positive Gilead Sciences 443
Testing effectiveness (Phase 2)Looking for participantsNCT06584227What this trial is testingAdebrelimab and Chidamide for Pancreatic CancerWho this might be right forPancreatic Cancer, Adult Liu Xiufeng 45
Early research (Phase 1)WithdrawnNCT06681870What this trial is testingASP1893 in Adults With Advanced CLDN6-positive Solid TumorsWho this might be right forCLDN6-positive Solid TumorOvarian CancerEndometrial Cancer+3 more Astellas Pharma Global Development, Inc.
Early research (Phase 1)Active Not RecruitingNCT05143970What this trial is testingFirst-In-Human Study of the Anti-CD73 IPH5301 Alone or in Combination With Chemotherapy and Trastuzumab in Patients With Advanced Solid TumorsWho this might be right forMetastatic CancerMetastatic Breast CancerMetastatic Pancreatic Cancer+6 more Institut Paoli-Calmettes 27
Testing effectiveness (Phase 2)Study completedNCT00344773What this trial is testingFirst-line Treatment for Adenocarcinoma Patients With Epidermal Growth Factor Receptor (EGFR) MutationWho this might be right forPulmonary Cancer AstraZeneca 46